Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
Category - Next generation sequencing
Tempus Announces the Acquisition of Paige
Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated Tempus AI, Inc. (NASDAQ: TEM), a technology company leading...read more
10x Genomics to Acquire Scale Biosciences
Acquisition Will Further Expand Chromium’s Capabilities PLEASANTON, Calif., Aug. 7, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology...read more
Ultima Genomics Selected to Support the World’s Largest Proteomics Studies to Date Led by Regeneron Genetics Center
FREMONT, Calif., June 26, 2025 /PRNewswire/ — Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that its...read more
